P2.06-06 Study Design to Assess Anti-TIGIT Mab Combination with Dostarlimab vs Pembrolizumab or Dostarlimab Monotherapy in NSCLC
| Autor: | Spigel, D.R., Cho, B.C., Reck, M., Nakagawa, K., Wimalasundera, S., Parkhomenko, E., Parasrampuria, R., Parker, L., Khaled, A., Satouchi, M. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology November 2023 18(11) Supplement:S319-S319 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|